• The Lancet Respiratory Medicine in conversation with

  • By: The Lancet Group
  • Podcast

The Lancet Respiratory Medicine in conversation with

By: The Lancet Group
Listen for free

  • Summary

  • Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.

    A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.
    © 2024 The Lancet Group
    Show more Show less
Biological Sciences Hygiene & Healthy Living Physical Illness & Disease
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Sergio Harari sul trattamento della linfangioleiomiomatosi (LAM) (in Italian)

    Sergio Harari sul trattamento della linfangioleiomiomatosi (LAM) (in Italian)
    Oct 25 2024

    Il Professor Sergio Harari commenta i risultati di un trial clinico di fase 2 volto a valutare l’attivita’ e la sicurezza del farmaco nintedanib come trattamento in pazienti affetti da linfangioleiomiomatosi (LAM).

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Show more Show less
    11 mins
  • Sergio Harari on the treatment of lymphangioleiomyomatosis (LAM)

    Sergio Harari on the treatment of lymphangioleiomyomatosis (LAM)
    Oct 25 2024

    Professor Sergio Harari joins us to discuss the results of a phase 2 clinical trial evaluating activity and safety of nintedanib in people with lymphangioleiomyomatosis (LAM).

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Show more Show less
    10 mins
  • Robert Kullberg on empirical antibiotics for Sepsis

    Robert Kullberg on empirical antibiotics for Sepsis
    Oct 11 2024

    Dr Robert Kullberg joins us to discuss his Viewpoint on empiric antibiotic therapy for sepsis and the importance of reducing unnecessary use of anti-anaerobic antibiotics.

    Read the full article:
    https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00257-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Show more Show less
    12 mins

What listeners say about The Lancet Respiratory Medicine in conversation with

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available